Want to join the conversation?
$OREX 2Q15 Call: OREX has agreed to pay for the new cardiovascular outcomes trial up to estimated $210MM total cost of study. If cost exceeds this estimate, the parties will share cost generally equally. Takeda will pay the remaining cost of closing MRI study. Takeda will also pay 75% of cost of all other development activities for Contrave in US.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?